Product Information
TEMAZEPAM 22.5 MG CAPSULE is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $1.9949 per EA under NDC 62332038130. Its NADAC has been published 361 times since Jul 31, 2019.
Strength
22.5 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332038130
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TEMAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA211542On Market Since
11/27/2018
Pharmacological Classes
Price Statistics
The NADAC for TEMAZEPAM 22.5 MG CAPSULE has been published 361 times since Jul 31, 2019, and over the history we have for it it has declined 46.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.9949 per EA |
|---|---|
| All-time high | $3.7033 (Aug 14, 2019) |
| All-time low | $1.1572 (Nov 20, 2024) |
| 52-week high | $2.0272 |
| 52-week low | $1.5147 |
| Median price | $2.2106 |
| Average price | $2.2757 |
| Largest weekly change | +81.6% (Mar 23, 2022) |
| Weeks tracked | 361 |
| Tracking since | Jul 31, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Temazepam market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of TEMAZEPAM 22.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMAZEPAM 22.5 MG CAPSULE, manufactured by Alembic Pharmaceuticals Inc., is $1.9949 per EA (NDC 62332038130), effective Jun 24, 2026.
How has the price of TEMAZEPAM 22.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMAZEPAM 22.5 MG CAPSULE has declined 46.1%. It has been tracked across 361 weekly CMS publications since Jul 31, 2019.
What are the highest and lowest recorded NADAC prices for TEMAZEPAM 22.5 MG CAPSULE?
Since Jul 31, 2019, the NADAC for TEMAZEPAM 22.5 MG CAPSULE has ranged from a low of $1.1572 (Nov 20, 2024) to a high of $3.7033 (Aug 14, 2019), with a median of $2.2106 per EA.
Are there cheaper alternatives to TEMAZEPAM 22.5 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of TEMAZEPAM 22.5 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures TEMAZEPAM 22.5 MG CAPSULE?
TEMAZEPAM 22.5 MG CAPSULE (NDC 62332038130) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification